Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

President Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

The Federal Trade Commission (FTC) has amended the Children’s Online Privacy Protection Act (COPPA) implementing regulations (COPPA Rule), including by requiring covered operators to obtain separate ...

The proposed rule also includes conforming amendments to related nutrient ... authorities found in the U.S. Federal Food, Drug, and Cosmetic Act, as amended by the Nutrition Labeling and Education ...

The Agency considered this information to be a major amendment to the application. The new Prescription Drug User Fee Act target date is now April 29, 2025. “We appreciate the FDA’s commitment to a ...

The Senate on Tuesday passed the Digital Nation Pakistan Bill 2025 and the Prevention of Electronic Crimes Act (Amendments) Bill, 2025 with a majority vote amid a ruckus by the opposition benches.

If the EUA amendment is granted, Invivyd plans to initiate a clinical study in collaboration with the FDA to further assess pemivibart's virologic profile. PEMGARDA is currently authorized for ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

The federal government is set to make harsher amendments to the Prevention of Electronic Crimes Act (PECA) 2016 via the PECA Act (Amendment) Bill 2025 to combat fake news and curb the misuse of ...

In fact, the Communications Act explicitly prohibits the Commission from censoring broadcasters. We must respect the protections of the First Amendment and the restrictions in the Communications ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...